An extensive screen of the HLA region reveals an independent association of HLA class I and class II with susceptibility for systemic lupus erythematosus

References

• Tsao B. P. Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 2004; 16: 513–21
   PubMed Web of Science ®Google Scholar
• Kelly J. A., Moser K. L., Harley J. B. The genetics of systemic lupus erythematosus: putting the pieces together. Genes Immun 2002; 3((Suppl 1))S71–85
   PubMedGoogle Scholar
• Croker J. A., Kimberly R. P. Genetics of susceptibility and severity in systemic lupus erythematosus. Curr Opin Rheumatol 2005; 17: 529–37
   PubMedGoogle Scholar
• Graham R. R., Ortmann W. A., Langefeld C. D., Jawaheer D., Selby S. A., Rodine P. R., et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 2002; 71: 543–53
   PubMed Web of Science ®Google Scholar
• Smerdel‐Ramoya A., Finholt C., Lilleby V., Gilboe I. M., Harbo H. F., Maslinski S., et al. Systemic lupus erythematosus and the extended major histocompatibility complex – evidence for several predisposing loci. Rheumatology (Oxford) 2005; 44: 1368–73
   PubMedGoogle Scholar
• Rood M. J., van Krugten M. V., Zanelli E., van der Linden M. W., Keijsers V., Schreuder G. M., et al. TNF‐308A and HLA‐DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000; 43: 129–34
   PubMed Web of Science ®Google Scholar
• Tsuchiya N., Kawasaki A., Tsao B. P., Komata T., Grossman J. M., Tokunaga K. Analysis of the association of HLA‐DRB1, TNFalpha promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test. Genes Immun 2001; 2: 317–22
   PubMedGoogle Scholar
• International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley J. B., Alarcón‐Riquelme M. E., Criswell L. A., Jacob C. O., Kimberly R. P., Moser K. L., et al. Genome‐wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40: 204–10
   PubMed Web of Science ®Google Scholar
• Fernando M. M., Stevens C. R., Sabeti P. C., Walsh E. C., McWhinnie A. J., Shah A., et al. Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet 2007; 3: e192
   PubMed Web of Science ®Google Scholar
• Wallace D. J., Hahn B. H. Dubois' lupus erythematosus. Lippincott Williams & Wilkins, Philadelphia 2002, 6th edn
   Google Scholar
• Lee Y. H., Nath S. K. Systemic lupus erythematosus susceptibility loci defined by genome scan meta‐analysis. Hum Genet 2005; 118: 434–43
   PubMed Web of Science ®Google Scholar
• Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
   PubMed Web of Science ®Google Scholar
• Beckmann L., Fischer C., Deck K. G., Nolte I. M., te Meerman G., Chang‐Claude J. Exploring haplotype sharing methods in general and isolated populations to detect gene(s) of a complex genetic trait. Genet Epidemiol 2001; 21((Suppl 1))S554–9
   PubMedGoogle Scholar
• Boon M., Nolte I. M., Bruinenberg M., Spijker G. T., Terpstra P., Raelson J., et al. Mapping of a susceptibility gene for multiple sclerosis to the 51 kb interval between G511525 and D6S1666 using a new method of haplotype sharing analysis. Neurogenetics 2001; 3: 221–30
   PubMedGoogle Scholar
• Levinson D. F., Kirby A., Slepner S., Nolte I., Spijker G. T., te Meerman G. Simulation studies of detection of a complex disease in a partially isolated population. Am J Med Genet 2001; 105: 65–70
   PubMedGoogle Scholar
• Martens H. A., Nolte I. M., van der Steege G., Schipper M., Kallenberg C. G., te Meerman G. J., et al. Association of poly(ADP‐ribose) polymerase 1 and a novel candidate locus, LOC127086, with systemic lupus erythematosus. Ann Rheum Dis 2007; 66: 424–5
   PubMedGoogle Scholar
• Sham P. C., Curtis D. An extended transmission/disequilibrium test (TDT) for multi‐allele marker loci. Ann Hum Genet 1995; 59((Pt 3))323–36
   PubMed Web of Science ®Google Scholar
• Spielman R. S., McGinnis R. E., Ewens W. J. Transmission test for linkage disequilibrium: the insulin gene region and insulin‐dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506–16
   PubMed Web of Science ®Google Scholar
• Spijker G. T., Nolte I. M., Jansen R. C., te Meerman G. J. Genetic association studies in complex disease: disentangling additional predisposing loci from associated neutral loci using a constrained‐permutation approach. Ann Hum Genet 2005; 69((Pt 1))90–101
   PubMedGoogle Scholar
• McHugh N. J., Owen P., Cox B., Dunphy J., Welsh K. MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus. Ann Rheum Dis 2006; 65: 488–94
   PubMedGoogle Scholar
• Diamond B., Katz J. B., Paul E., Aranow C., Lustgarten D., Scharff M. D. The role of somatic mutation in the pathogenic anti‐DNA response. Annu Rev Immunol 1992; 10: 731–57
   PubMed Web of Science ®Google Scholar
• Graham R. R., Ortmann W., Rodine P., Espe K., Langefeld C., Lange E., et al. Specific combinations of HLA‐DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet 2007; 15: 823–30
   PubMed Web of Science ®Google Scholar
• Gambelunghe G., Gerli R., Bocci E. B., Del Sindaco P., Ghaderi M., Sanjeevi C. B., et al. Contribution of MHC class I chain‐related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus. Rheumatology (Oxford) 2005; 44: 287–92
   PubMedGoogle Scholar
• Morgan B. P., Walport M. J. Complement deficiency and disease. Immunol Today 1991; 12: 301–6
   PubMedGoogle Scholar
• Pickering M. C., Walport M. J. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology (Oxford) 2000; 39: 133–41
   PubMed Web of Science ®Google Scholar
• Studnicka‐Benke A., Steiner G., Petera P., Smolen J. S. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol 1996; 35: 1067–74
   PubMedGoogle Scholar
• Lee Y. H., Harley J. B., Nath S. K. Meta‐analysis of TNF‐alpha promoter –308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet 2006; 14: 364–71
   PubMed Web of Science ®Google Scholar
• Diepstra A., Niens M., Vellenga E., van Imhoff G. W., Nolte I. M., Schaapveld M., et al. Association with HLA class I in Epstein–Barr‐virus‐positive and with HLA class III in Epstein–Barr‐virus‐negative Hodgkin's lymphoma. Lancet 2005; 365: 2216–24
   PubMed Web of Science ®Google Scholar